[
    {
        "question_id": "4370_B_14",
        "new_question_id": "12507",
        "question_type": "0",
        "category": "7",
        "concept_id_link": "1565",
        "notes_id_link": "1_1450",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Continue avoiding milk lifelong",
            "Initiate the milk ladder starting with malted milk biscuits",
            "Initiate the milk ladder starting with digestive biscuits",
            "Advise regular chlorpheniramine",
            "Prescribe an adrenaline pen",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "James, a 6-month-old with known non-IgE mediated cows milk protein allergy is reviewed by yourself in the allergy clinic. His mum is concerned that he will have to avoid milk long term. He currently avoids all milk based products. What treatment advice should you give?",
            "",
            ""
        ],
        "answers": [
            "2",
            "0",
            "0"
        ],
        "notes": [
            "Children with cows milk protein allergy often respond to the milk ladder whereby milk is gradually introduced into the diet in stages. The first step is malted milk biscuits, then digestive biscuits with later steps including chocolate and yoghurt.<br /><br />Chlorpheniramine (piriton) is not recommended in this age group as it is sedating.<br /><br />An epipen is not required in non IgE mediated allergy.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "James, a 6-month-old with known non-IgE mediated cows milk protein allergy is reviewed by yourself in the allergy clinic. His mum is concerned that he will have to avoid milk long term. He currently avoids all milk based products. What treatment advice should you give?",
        "correct_answer": "2",
        "question_notes": "Children with cows milk protein allergy often respond to the milk ladder whereby milk is gradually introduced into the diet in stages. The first step is malted milk biscuits, then digestive biscuits with later steps including chocolate and yoghurt.<br /><br />Chlorpheniramine (piriton) is not recommended in this age group as it is sedating.<br /><br />An epipen is not required in non IgE mediated allergy.",
        "answer_order": "2",
        "answer": "2",
        "title": "Cow's milk protein intolerance/allergy",
        "body": "Cow's milk protein intolerance/allergy (CMPI/CMPA) occurs in around 3-6% of all children and typically <span class=\"concept\" data-cid=\"1995\">presents in the first 3 months of life in formula-fed infants</span>, although rarely it is seen in <span class=\"concept\" data-cid=\"1997\">exclusively breastfed infants</span>. <br /><br />Both immediate (IgE mediated) and delayed (non-IgE mediated) reactions are seen. The term CMPA is usually used for immediate reactions and CMPI for mild-moderate delayed reactions.<br /><br />Features<br /><ul><li>regurgitation and vomiting</li><li>diarrhoea</li><li>urticaria, atopic eczema</li><li>'colic' symptoms: irritability, crying</li><li>wheeze, chronic cough</li><li>rarely angioedema and anaphylaxis may occur</li></ul><br />Diagnosis is often clinical (e.g. improvement with cow's milk protein elimination). Investigations include:<br /><ul><li>skin prick/patch testing</li><li>total IgE and specific IgE (RAST) for cow's milk protein</li></ul><br /><h5 class='notes-heading'>Management</h5><br />If the <span class=\"concept\" data-cid=\"1996\">symptoms are severe (e.g. failure to thrive) refer to a paediatrician</span>.<br /><br />Management if formula-fed<br /><ul><li><span class=\"concept\" data-cid=\"11483\">extensive hydrolysed formula</span> (eHF) milk is the first-line replacement formula for infants with mild-moderate symptoms</li><li><span class=\"concept\" data-cid=\"11484\">amino acid-based formula</span> (AAF) in infants with severe CMPA or if no response to eHF</li><li><span class=\"concept\" data-cid=\"1999\">around 10% of infants are also intolerant to soya milk</span></li></ul><br />Management if breastfed<br /><ul><li>continue breastfeeding</li><li>eliminate cow's milk protein from maternal diet. <span class=\"concept\" data-cid=\"9562\">Consider prescribing calcium supplements</span> for breastfeeding mothers whose babies have, or are suspected to have, CMPI, to prevent deficiency whilst they exclude dairy from their diet </li><li>use eHF milk when breastfeeding stops, until 12 months of age and at least for 6 months</li></ul><br /><h5 class='notes-heading'>Prognosis</h5><br />CMPI usually resolves in most children<br /><ul><li>in children with IgE mediated intolerance around 55% will be milk tolerant by the age of 5 years</li><li><span class=\"concept\" data-cid=\"1998\">in children with non-IgE mediated intolerance most children will be milk tolerant by the age of 3 years</span></li><li>a challenge is often performed in the hospital setting as anaphylaxis can occur.</li></ul>",
        "notes_hash": "7c6321794c862ff5912a3b14b581afa5",
        "knowledge_graph_node_id_link": 1233,
        "concept": "Children with non IgE mediated cows milk protein allergy are  more likely to overcome their allergy at a younger age compared with IgE mediated allergies",
        "concept_percentile": "65",
        "concept_colour": "rgb(178,255,0)",
        "number_attempts": "4827",
        "up_votes": "30",
        "down_votes": "57",
        "column_array": [
            0,
            "217",
            "3858",
            "634",
            "35",
            "83",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>NHS Choices</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_425\" data-linkid=\"425\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_425\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">12</span><button type=\"button\" style=\"\" id=\"link_dislike_425\" data-linkid=\"425\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_425\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">10</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"http://www.nhs.uk/conditions/pregnancy-and-baby/pages/types-of-infant-formula.aspx#close\">Types of infant formula</a></td></tr></table>",
        "media": "",
        "comment_count": 10,
        "concepts_for_notes": {
            "1995": {
                "concept_text": "Cows milk protein allergy typically presents in the first 3 months of life in formula-fed infants",
                "concept_percentile": "21"
            },
            "11483": {
                "concept_text": "If a formula-fed baby is suspected of having mild-moderate cow's milk protein intolerance then a extensive hydrolysed formula should be tried",
                "concept_percentile": "55"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "999_B_2384",
        "new_question_id": "61673",
        "question_type": "0",
        "category": "12",
        "concept_id_link": "12295",
        "notes_id_link": "1_327",
        "theme": "Newly diagnosed highly symptomatic asthma initial management choice",
        "instruction": "",
        "options": [
            "",
            "Low-dose ICS/formoterol as needed only",
            "Low-dose ICS/formoterol MART",
            "Moderate-dose ICS/formoterol MART",
            "Salbutamol as needed plus regular low-dose ICS",
            "Salbutamol as needed plus oral prednisolone",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 28-year-old woman presents to her GP with a 3-week history of worsening breathlessness and wheeze. She wakes most nights coughing and has been using her friend's salbutamol inhaler multiple times daily. She has no significant past medical history. Examination reveals widespread polyphonic wheeze. Peak flow is 65% of predicted.<br /><br />Select the single most appropriate initial management from the options below.",
            "",
            ""
        ],
        "answers": [
            "2",
            "",
            ""
        ],
        "notes": [
            "<b>Low-dose ICS/formoterol MART</b> is the correct answer for this patient presenting with highly symptomatic newly diagnosed asthma. According to the 2024 NICE/BTS/SIGN joint guidelines, when an adult presents with highly symptomatic asthma (such as regular nocturnal waking) or with a severe exacerbation, clinicians should treat the acute symptoms and start low-dose MART (maintenance and reliever therapy) immediately, bypassing Step 1. This patient demonstrates clear features of highly symptomatic asthma with regular nocturnal waking, frequent use of bronchodilators, and reduced peak flow. MART involves using an ICS/formoterol combination inhaler both regularly for maintenance and as needed for symptom relief. This approach provides both anti-inflammatory control and bronchodilation, addressing the underlying pathophysiology whilst managing acute symptoms. The formoterol component has both rapid onset (suitable for relief) and long duration of action (suitable for maintenance), making it ideal for this dual-purpose strategy.<br /><br /><b>Low-dose ICS/formoterol as needed only</b> represents Step 1 of the new asthma guidelines, which is appropriate for patients with newly diagnosed asthma who are not highly symptomatic. This is termed anti-inflammatory reliever (AIR) therapy. However, this patient's presentation with regular nocturnal waking and significant symptoms means she meets the criteria for highly symptomatic asthma, warranting immediate progression to MART rather than starting with as-needed therapy alone. Using this approach would likely result in inadequate symptom control given the severity of her presentation.<br /><br /><b>Moderate-dose ICS/formoterol MART</b> represents Step 3 of the guidelines and would be excessive as initial therapy for this patient. The guidelines advocate a stepwise approach, and whilst this patient requires MART due to being highly symptomatic, she should start with low-dose MART first. Moderate-dose MART is reserved for patients whose asthma remains uncontrolled on low-dose MART. Starting at too high a step exposes patients to unnecessary higher doses of corticosteroids without evidence of inadequate response to lower doses.<br /><br /><b>Salbutamol as needed plus regular low-dose ICS</b> represents the traditional approach to asthma management from previous guidelines. The 2024 joint guidelines have moved away from this strategy for newly diagnosed patients, instead favouring combination inhalers that provide both anti-inflammatory and bronchodilator effects. This approach separates the reliever (SABA) from the preventer (ICS), which can lead to patients using only their reliever during exacerbations without receiving anti-inflammatory treatment. The new guidelines recognise that combining these in a single inhaler improves adherence and outcomes.<br /><br /><b>Salbutamol as needed plus oral prednisolone</b> addresses only the acute exacerbation component without establishing appropriate maintenance therapy. Whilst a course of oral corticosteroids may be indicated for treating acute symptoms in highly symptomatic presentations, the guidelines emphasise that MART should be started concurrently. Using SABA alone as the inhaled therapy fails to provide the necessary regular anti-inflammatory control and does not align with current best practice. This option would require the patient to return for further management planning rather than establishing definitive treatment immediately.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 28-year-old woman presents to her GP with a 3-week history of worsening breathlessness and wheeze. She wakes most nights coughing and has been using her friend's salbutamol inhaler multiple times daily. She has no significant past medical history. Examination reveals widespread polyphonic wheeze. Peak flow is 65% of predicted.<br /><br />Select the single most appropriate initial management from the options below.",
        "correct_answer": "2",
        "question_notes": "<b>Low-dose ICS/formoterol MART</b> is the correct answer for this patient presenting with highly symptomatic newly diagnosed asthma. According to the 2024 NICE/BTS/SIGN joint guidelines, when an adult presents with highly symptomatic asthma (such as regular nocturnal waking) or with a severe exacerbation, clinicians should treat the acute symptoms and start low-dose MART (maintenance and reliever therapy) immediately, bypassing Step 1. This patient demonstrates clear features of highly symptomatic asthma with regular nocturnal waking, frequent use of bronchodilators, and reduced peak flow. MART involves using an ICS/formoterol combination inhaler both regularly for maintenance and as needed for symptom relief. This approach provides both anti-inflammatory control and bronchodilation, addressing the underlying pathophysiology whilst managing acute symptoms. The formoterol component has both rapid onset (suitable for relief) and long duration of action (suitable for maintenance), making it ideal for this dual-purpose strategy.<br /><br /><b>Low-dose ICS/formoterol as needed only</b> represents Step 1 of the new asthma guidelines, which is appropriate for patients with newly diagnosed asthma who are not highly symptomatic. This is termed anti-inflammatory reliever (AIR) therapy. However, this patient's presentation with regular nocturnal waking and significant symptoms means she meets the criteria for highly symptomatic asthma, warranting immediate progression to MART rather than starting with as-needed therapy alone. Using this approach would likely result in inadequate symptom control given the severity of her presentation.<br /><br /><b>Moderate-dose ICS/formoterol MART</b> represents Step 3 of the guidelines and would be excessive as initial therapy for this patient. The guidelines advocate a stepwise approach, and whilst this patient requires MART due to being highly symptomatic, she should start with low-dose MART first. Moderate-dose MART is reserved for patients whose asthma remains uncontrolled on low-dose MART. Starting at too high a step exposes patients to unnecessary higher doses of corticosteroids without evidence of inadequate response to lower doses.<br /><br /><b>Salbutamol as needed plus regular low-dose ICS</b> represents the traditional approach to asthma management from previous guidelines. The 2024 joint guidelines have moved away from this strategy for newly diagnosed patients, instead favouring combination inhalers that provide both anti-inflammatory and bronchodilator effects. This approach separates the reliever (SABA) from the preventer (ICS), which can lead to patients using only their reliever during exacerbations without receiving anti-inflammatory treatment. The new guidelines recognise that combining these in a single inhaler improves adherence and outcomes.<br /><br /><b>Salbutamol as needed plus oral prednisolone</b> addresses only the acute exacerbation component without establishing appropriate maintenance therapy. Whilst a course of oral corticosteroids may be indicated for treating acute symptoms in highly symptomatic presentations, the guidelines emphasise that MART should be started concurrently. Using SABA alone as the inhaled therapy fails to provide the necessary regular anti-inflammatory control and does not align with current best practice. This option would require the patient to return for further management planning rather than establishing definitive treatment immediately.",
        "answer_order": "2",
        "answer": "2",
        "title": "Asthma: management in adults",
        "body": "In 2024 NICE, the British Thoracic Society and SIGN produced joint guidelines on the management of asthma following many years of conflicting guidelines. The new guidelines represent a major step change in the management of asthma is both diagnosed and treated.<br /><br />For many years patients with asthma were started on a short-acting beta-2 agonist (SABA) inhaler before 'stepping up' to a regular inhaled corticosteroid with a SABA as required. The new guidelines now advocate the use of combined inhalers (ICS + long-acting beta-2 agonist) as reliever therapy or regularly, depending on the severity of asthma. Given the prevalence of asthma, it is likely that doctors will have to deal with patients on 'conventional' asthma treatments for many years to come. The joint guidelines therefore include guidance on how to manage these patients if their current treatment is controlling their symptoms sufficiently.<br /><br /><h5 class='notes-heading'>Management of adult patients aged children aged \u2265 12 years with newly diagnosed asthma</h5><br />Step 1 <a href='https://www.nice.org.uk/guidance/ng245/chapter/Recommendations#pharmacological-management-in-people-aged-12-and-over:~:text=and%20over.-,Initial%20management%20of%20newly%20diagnosed%20asthma%20in%20people%20aged%2012%20and%20over,-1.7.1' title='NICE - 2024 Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN)' target='_blank' class='badge rounded-pill text-bg-light deeplink'>NICE</a><ul><li>a <span class=\"concept\" data-cid=\"12286\">low-dose inhaled corticosteroid (ICS)/formoterol combination inhaler to be taken as needed for symptom relief</span><ul><li>this is termed anti-inflammatory reliever (AIR) therapy</li></ul></li><li>if the patient presents highly symptomatic (for example, regular nocturnal waking) or with a severe exacerbation:<ul><li><span class=\"concept\" data-cid=\"12295\">start treatment with low-dose MART</span> (maintenance and reliever therapy, see below)</li><li>treat the acute symptoms as appropriate (e.g. a course of oral corticosteroids may be indicated)</li></ul></li></ul><br />Step 2  <a href='https://www.nice.org.uk/guidance/ng245/chapter/Recommendations#pharmacological-management-in-people-aged-12-and-over:~:text=asthma%20management.-,Medicine%20combination%20and%20sequencing%20in%20people%20aged%2012%20and%20over,-For%20guidance%20on' title='NICE - 2024 Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN)' target='_blank' class='badge rounded-pill text-bg-light deeplink'>NICE</a> <br /><ul><li><span class=\"concept\" data-cid=\"12287\">a low-dose MART</span><ul><li>MART describes using an inhaled corticosteroid (ICS)/formoterol combination inhaler for daily maintenance therapy and the relief of symptoms as needed, i.e. regularly and as required</li></ul></li></ul><br />Step 3<br /><ul><li>a <span class=\"concept\" data-cid=\"12288\">moderate-dose MART</span></li></ul><br />Step 4<br /><ul><li><span class=\"concept\" data-cid=\"12289\">check the fractional exhaled nitric oxide (FeNO) level if available, and the blood eosinophil count</span>  <a href='https://www.nice.org.uk/guidance/ng245/chapter/Recommendations#pharmacological-management-in-people-aged-12-and-over:~:text=Check%20the%20fractional%20exhaled%20nitric%20oxide%20(FeNO)%20level%20if%20available' title='NICE - 2024 Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN)' target='_blank' class='badge rounded-pill text-bg-light deeplink'>NICE</a> <ul><li>if <span class=\"concept\" data-cid=\"12290\">either of these is raised, refer to a specialist in asthma care</span></li><li>if <span class=\"concept\" data-cid=\"12291\">neither FeNO nor eosinophil count is raised, consider a trial of either a leukotriene receptor antagonist (LTRA) or a long-acting muscarinic receptor antagonist (LAMA)</span> used in addition to moderate-dose MART</li><li>if control has not improved, stop the LTRA or LAMA and start a trial of the alternative medicine (LTRA or LAMA)</li></ul></li></ul><br />Step 5<br /><ul><li><span class=\"concept\" data-cid=\"12292\">refer people to a specialist in asthma care</span> when asthma is not controlled despite treatment with moderate-dose MART, and trials of an LTRA and a LAMA</li></ul><br /><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd602b.png\" data-fancybox=\"gallery\" data-caption=\"Algorithm showing pharmacological management of asthma in people aged 12 years and over\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd602.png\" alt=\"\" /></a></div></div></div><br /><h5 class='notes-heading'>Transferring people aged 12 and over from other treatment pathways</h5><br />There will be many people whose asthma was managed according to the previous guidelines that present with uncontrolled asthmatic symptoms. The guidelines give advice on how these people should be switched:  <a href='https://www.nice.org.uk/guidance/ng245/chapter/Recommendations#pharmacological-management-in-people-aged-12-and-over:~:text=asthma%20management.-,Transferring%20people%20aged%2012%20and%20over%20from%20other%20treatment%20pathways,-These%20recommendations%20are' title='NICE - 2024 Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN)' target='_blank' class='badge rounded-pill text-bg-light deeplink'>NICE</a> <br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th>Existing asthma treatment</th><th>New asthma treatment</th></tr></thead><tbody><tr><td>SABA as required only</td><td><span class=\"concept\" data-cid=\"12293\"> Low-dose ICS/formoterol combination inhaler used as needed (as-needed AIR therapy)</span></td></tr><tr><td>SABA as required + regular low-dose ICS<br />SABA as required + regular low-dose ICS/LABA <br />SABA as required + regular low-dose ICS + LTRA <br />SABA as required + regular low-dose ICS/LABA + LTRA</td><td><span class=\"concept\" data-cid=\"12294\">Regular low-dose regular ICS/formoterol combination inhaler (MART therapy)</span></td></tr><tr><td>SABA as required + regular moderate-dose ICS<br />SABA as required + regular moderate-dose ICS/LABA  <br />SABA as required + regular moderate-dose ICS + LTRA or LAMA<br />SABA as required + regular moderate-dose ICS/LABA + LTRA or LAMA</td><td>Regular moderate-dose MART therapy</td></tr><tr><td>Treatment regime containing a high-dose ICS</td><td>Refer to a respiratory specialist</td></tr></tbody></table></div>",
        "notes_hash": "b11ce0ccb8c27014563f244a47ea595b",
        "knowledge_graph_node_id_link": 11377,
        "concept": "If an adult presents with highly symptomatic asthma (for example, regular nocturnal waking) or with a severe exacerbation then treat the acute symptoms and start MART",
        "concept_percentile": "100",
        "concept_colour": "rgb(0,255,0)",
        "number_attempts": "262",
        "up_votes": "0",
        "down_votes": "0",
        "column_array": [
            0,
            "125",
            "111",
            "3",
            "16",
            "7",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_2123\" data-linkid=\"2123\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_2123\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">48</span><button type=\"button\" style=\"\" id=\"link_dislike_2123\" data-linkid=\"2123\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_2123\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">11</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng245/chapter/Recommendations\">2024 Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN)</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/hjdIyyC8T-E\" data-description=\"Inhaler and Nebuliser Explanation\" data-upvotes=\"3\" data-downvotes=\"1\" data-media=\"131\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/hjdIyyC8T-E/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/hjdIyyC8T-E\" data-description=\"Inhaler and Nebuliser Explanation\" data-upvotes=\"3\" data-downvotes=\"1\" data-media=\"131\">Inhaler and Nebuliser Explanation</a></td></tr><tr><td><span ><small>Oxford Medical Education - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_225\" data-mediaid=\"225\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_225\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">3</span><button type=\"button\" style=\"\" id=\"media_dislike_225\" data-mediaid=\"225\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_225\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr></table>",
        "comment_count": 0,
        "concepts_for_notes": {
            "12286": {
                "concept_text": "Asthma: adults and children \u2265 12 years first-line treatment --> low-dose inhaled corticosteroid (ICS)/formoterol combination inhaler as required",
                "concept_percentile": "55"
            },
            "12287": {
                "concept_text": "Asthma: adults and children \u2265 12 years second-line treatment --> low-dose inhaled corticosteroid (ICS)/formoterol combination inhaler regularly and as required (MART)",
                "concept_percentile": "35"
            },
            "12288": {
                "concept_text": "Asthma: adults and children \u2265 12 years not controlled on low-dose MART --> moderate-dose MART\n",
                "concept_percentile": "27"
            },
            "12289": {
                "concept_text": "Asthma: adults not controlled on moderate-dose MART --> check the FeNO level if available, and the blood eosinophil count",
                "concept_percentile": "36"
            },
            "12290": {
                "concept_text": "Asthma: adults not controlled on moderate-dose MART - if either FeNO level or blood eosinophil raised then --> refer to a respiratory specialist",
                "concept_percentile": "35"
            },
            "12291": {
                "concept_text": "Asthma: adults not controlled on moderate-dose MART - if neither FeNO level nor blood eosinophil raised -->  trial of either a LTRA or a LAMA",
                "concept_percentile": "49"
            },
            "12292": {
                "concept_text": "Refer adults to a respiratory specialist when asthma is not controlled despite treatment with moderate-dose MART, and trials of an LTRA and a LAMA",
                "concept_percentile": "20"
            },
            "12294": {
                "concept_text": "Adults with asthma who are poorly controlled on SABA prn + regularly ICS --> regular low-dose regular ICS/formoterol combination inhaler (MART therapy)",
                "concept_percentile": "100"
            },
            "12295": {
                "concept_text": "If an adult presents with highly symptomatic asthma (for example, regular nocturnal waking) or with a severe exacerbation then treat the acute symptoms and start MART",
                "concept_percentile": "100"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_2100",
        "new_question_id": "6605",
        "question_type": "0",
        "category": "9",
        "concept_id_link": "0",
        "notes_id_link": "1_2197",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Nasal fracture",
            "Orbital fracture",
            "Traumatic brain injury",
            "Fracture of the cervical spine",
            "Basilar skull fracture",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "Claire, 36, is brought in to the Emergency Department following falling down the stairs at home. On arrival it is noted that she has periorbital and post auricular bruising. What is this highly suggestive of?",
            "",
            ""
        ],
        "answers": [
            "5",
            "",
            ""
        ],
        "notes": [
            "The correct answer for this question is basilar skull fracture.<br /><br />The symptoms that are mentioned in the question are two of the classical signs synonymous with basilar skull fractures; periorbital bruising referring to the bruising around the eye that is otherwise known as Raccoon eyes, and post-auricular bruising referring to bruising of the mastoid otherwise known as Battle's sign.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "Claire, 36, is brought in to the Emergency Department following falling down the stairs at home. On arrival it is noted that she has periorbital and post auricular bruising. What is this highly suggestive of?",
        "correct_answer": "5",
        "question_notes": "The correct answer for this question is basilar skull fracture.<br /><br />The symptoms that are mentioned in the question are two of the classical signs synonymous with basilar skull fractures; periorbital bruising referring to the bruising around the eye that is otherwise known as Raccoon eyes, and post-auricular bruising referring to bruising of the mastoid otherwise known as Battle's sign.",
        "answer_order": "5",
        "answer": "5",
        "title": "Head injury: NICE guidance on investigation",
        "body": "NICE has strict and clear guidance regarding which adult patients are safe to discharge and which need further CT head imaging. The latter group are also divided into two further cohorts, those who require an immediate CT head and those requiring CT head within 8 hours of injury:<br /><br />CT head within 1 hour<br /><ul><li>GCS < 13 on initial assessment</li><li>GCS < 15 at 2 hours post-injury</li><li><span class=\"concept\" data-cid=\"11744\">suspected open or depressed skull fracture</span></li><li>any sign of basal skull fracture (haemotympanum, 'panda' eyes, cerebrospinal fluid leakage from the ear or nose, Battle's sign).</li><li>post-traumatic seizure.</li><li>focal neurological deficit.</li><li><span class=\"concept\" data-cid=\"11888\">more than 1 episode of vomiting</span></li></ul><br />CT head scan within 8 hours of the head injury - for adults with any of the following risk factors who have experienced some loss of consciousness or amnesia since the injury:<br /><ul><li>age <span class=\"concept\" data-cid=\"11745\">65 years or older</span></li><li>any history of bleeding or clotting disorders including <span class=\"concept\" data-cid=\"2710\">anticogulants</span></li><li>dangerous mechanism of injury (a pedestrian or cyclist struck by a motor vehicle, an occupant ejected from a motor vehicle or a fall from a height of greater than 1 metre or 5 stairs)</li><li>more than 30 minutes' retrograde amnesia of events immediately before the head injury</li></ul><br />If a patient is on warfarin who have sustained a head injury with no other indications for a CT head scan, perform a CT head scan within 8 hours of the injury.",
        "notes_hash": "585a8162b2c67c4fec665cd148dc128c",
        "knowledge_graph_node_id_link": 11199,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "5068",
        "up_votes": "43",
        "down_votes": "16",
        "column_array": [
            0,
            "24",
            "265",
            "79",
            "11",
            "4689",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1194\" data-linkid=\"1194\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1194\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">17</span><button type=\"button\" style=\"\" id=\"link_dislike_1194\" data-linkid=\"1194\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1194\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">20</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/cg176/chapter/1-Recommendations\">2014 Head injury guidelines</a></td></tr></table>",
        "media": "",
        "comment_count": 2,
        "concepts_for_notes": {
            "11888": {
                "concept_text": "Following a head injury, more than 1 episode of vomiting is an indication for a CT head within 1 hour",
                "concept_percentile": "85"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "14039_B_26",
        "new_question_id": "22484",
        "question_type": "0",
        "category": "8",
        "concept_id_link": "10734",
        "notes_id_link": "1_2922",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Cyclizine",
            "Domperidone",
            "Haloperidol",
            "Metoclopramide",
            "Ondansetron",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 74-year-old woman with a breast cancer attends a clinic with palliative care due to a recent diagnosis of brain metastases. She reports feeling nauseous and vomited several times in the past week. She asks for some medication to ease these symptoms.<br /><br />Which is the best anti-emetic to prescribe in the first instance?",
            "",
            ""
        ],
        "answers": [
            "1",
            "0",
            "0"
        ],
        "notes": [
            "Raised ICP from her metastases can stimulate H1 receptors in the cerebral cortex, causing the symptoms of nausea and vomiting. H1 receptor antagonists, such as cyclizine, are a good choice to combat these symptoms.<br /><br />Dexamethasone can also be used to reduce nausea and vomiting in the context of raised ICP.<br /><br />Domperidone and metoclopramide are useful for nausea and vomiting when caused by gastric stasis.<br /><br />Metoclopramide and haloperidol are useful for nausea induced by drugs (such as chemotherapy) and toxins.<br /><br />Ondansetron is good for chemically mediated symptoms, for example, from opioids.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 74-year-old woman with a breast cancer attends a clinic with palliative care due to a recent diagnosis of brain metastases. She reports feeling nauseous and vomited several times in the past week. She asks for some medication to ease these symptoms.<br /><br />Which is the best anti-emetic to prescribe in the first instance?",
        "correct_answer": "1",
        "question_notes": "Raised ICP from her metastases can stimulate H1 receptors in the cerebral cortex, causing the symptoms of nausea and vomiting. H1 receptor antagonists, such as cyclizine, are a good choice to combat these symptoms.<br /><br />Dexamethasone can also be used to reduce nausea and vomiting in the context of raised ICP.<br /><br />Domperidone and metoclopramide are useful for nausea and vomiting when caused by gastric stasis.<br /><br />Metoclopramide and haloperidol are useful for nausea induced by drugs (such as chemotherapy) and toxins.<br /><br />Ondansetron is good for chemically mediated symptoms, for example, from opioids.",
        "answer_order": "1",
        "answer": "1",
        "title": "Palliative care prescribing: nausea and vomiting",
        "body": "Nausea and vomiting in palliative care is often multi-factorial, however it is still important to identify the most prominent cause in order to guide choice of anti-emetic therapy. Six potential syndromes have been identified in palliative care, with gastric stasis and chemical disturbance being the most common and prominent. <br /><br /><b>Six broad nausea and vomiting syndromes</b>   <br /><ul><li>Reduced gastric motility<ul><li>May be opioid related</li><li>Related to serotonin (5HT4) and dopamine (D2) receptors</li></ul></li><li>Chemically mediated<ul><li>Secondary to hypercalcaemia, opioids, or chemotherapy</li></ul></li><li>Visceral/serosal<ul><li>Due to constipation</li><li>Oral candidiasis</li></ul></li><li>Raised intra-cranial pressure<ul><li>Usually in context of cerebral metastases </li></ul></li><li>Vestibular<ul><li>Related to activation of acetylcholine and histamine (H1) receptors </li><li>Most frequently in palliative care is opioid related</li><li>Can be motion related, or due to base of skull tumours </li></ul></li><li>Cortical<ul><li>May be due to anxiety, pain, fear and/or anticipatory nausea </li><li>Related to GABA and histamine (H1) receptors in the cerebral cortex</li></ul></li></ul><br />In palliative care, pharmacological therapy is the usually the first-line method for treating nausea and vomiting. In general, there are two approaches to choosing drug therapy, either empirical or mechanistic. An empirical approach involves choosing medication based on either physician preference or commonly a dopamine antagonist (e.g. metoclopramide) is used first-line. Alternatively, the mechanistic approach utilises matching choice of anti-emetic drug to the likely cause of the patient's nausea and vomiting. <br /><br /><b>Mechanistic approach</b><br /><ul><li>Reduced gastric motility<ul><li>Pro-kinetic agents are useful in these scenarios as the nausea and vomiting is usually resulting from gastric dysmotility and stasis</li><li><concept10852Pro-kinetic agents are often dopamine (D2) receptor antagonists</span></li><li>According to BMJ best practice, first-line medications include metoclopramide and domperidone  </li><li>However, NICE indicate that metoclopramide should not be used when pro-kinesis may negatively affect the gastrointestinal tract, particularly in complete bowel obstruction, gastrointestinal perforation, or immediately following gastric surgery</li></ul></li><li>Chemically mediated<ul><li>If possible, the chemical disturbance should be corrected first </li><li>In the context of other chemically mediated syndromes, for example due to opioid medications, there are a number of suggested medications </li><li>Key treatment options include ondansetron, haloperidol and levomepromazine </li></ul></li><li>Visceral/serosal causes<ul><li>Cyclizine and levomepromazine are first-line </li><li>Anti-cholinergics such as hyoscine can be useful </li></ul></li><li>Raised intra-cranial pressure<ul><li><span class=\"concept\" data-cid=\"10734\">Cyclizine</span>is recommended first-line for nausea and vomiting due to intracranial disease</li><li>Dexamethasone can also be usd</li><li>Radiotherapy can be considered if there is likely raised intra-cranial pressure due to cranial tumours</li></ul></li><li>Vestibular<ul><li>BMJ best practice recommends use of cyclizine as a first-line treatment in disorders due to the vestibular system</li><li>Refractory vestibular causes of nausea and vomiting can be treated alternatively with metoclopramide or prochlorperazine</li><li>Atypical antipsychotics such as olanzapine or risperidone can be used in refractory cases according to UptoDate </li></ul></li><li>Cortical<ul><li>If anticipatory nausea is the clear cause, a short acting benzodiazepine such as lorazepam can be useful </li><li>If benzodiazepines are not ideal, BMJ best practice recommends use of cyclizine </li><li>Ondansetron and metoclopramide can also be trialled</li></ul></li></ul><br /><b>Route of administration</b><br /><ul><li>oral anti-emetics are preferable and therefore should be used if possible</li><li>Situations where use of oral medications may not be possible include if the patient is vomiting, has issues with malabsorption, or there is severe gastric stasis </li><li>If the oral route is not possible the parenteral route of administration is preferred</li><li>The intravenous route can be use if intravenous access is already established</li></ul>",
        "notes_hash": "22c51cc14f5fe24e4a40d82103d46c0f",
        "knowledge_graph_node_id_link": 0,
        "concept": "Cyclizine is a good first line anti-emetic for intracranial causes of nausea and vomiting",
        "concept_percentile": "96",
        "concept_colour": "rgb(20,255,0)",
        "number_attempts": "5708",
        "up_votes": "36",
        "down_votes": "16",
        "column_array": [
            0,
            "3184",
            "247",
            "297",
            "684",
            "1296",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "",
        "comment_count": 2,
        "concepts_for_notes": {
            "10734": {
                "concept_text": "Cyclizine is a good first line anti-emetic for intracranial causes of nausea and vomiting",
                "concept_percentile": "96"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_158",
        "new_question_id": "7638",
        "question_type": "0",
        "category": "2",
        "concept_id_link": "0",
        "notes_id_link": "1_277",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Promethazine",
            "Prochlorperazine",
            "Betahistine",
            "Chlorphenamine",
            "Cinnarizine",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "Which one of the following medications is most useful for helping to prevent attacks of Meniere's disease?",
            "",
            ""
        ],
        "answers": [
            "3",
            "",
            ""
        ],
        "notes": [
            "The correct answer is <b>Betahistine</b>. Betahistine is a histamine analogue that works by improving the microcirculation and pressure of the inner ear, which helps to relieve symptoms associated with Meniere's disease such as vertigo, tinnitus, hearing loss and aural fullness. It is commonly used in the UK for the prophylaxis of this condition due to its effectiveness and relatively low side effect profile.<br /><br /><b>Promethazine</b> and <b>Prochlorperazine</b> are both antiemetics that can be used to manage acute episodes of vertigo associated with Meniere's disease. However, they do not prevent attacks from occurring. Instead, these medications work by blocking dopamine receptors in the brain's vomiting centre and chemoreceptor trigger zone, respectively. This helps to reduce nausea and vomiting during an attack but does not address the underlying pathology causing the symptoms.<br /><br /><b>Chlorphenamine</b> is an antihistamine primarily used for symptomatic relief of allergic conditions including rhinitis and urticaria. While it may have some minor effects on reducing fluid build-up in the inner ear due to its antihistamine properties, it is not typically used in the management or prevention of Meniere's disease.<br /><br />Finally, <b>Cinnarizine</b> is an antihistamine and calcium channel blocker that can also be used in managing vertigo symptoms. However, like Promethazine and Prochlorperazine, it does not prevent attacks from occurring but rather provides symptomatic relief during an episode of vertigo.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "Which one of the following medications is most useful for helping to prevent attacks of Meniere's disease?",
        "correct_answer": "3",
        "question_notes": "The correct answer is <b>Betahistine</b>. Betahistine is a histamine analogue that works by improving the microcirculation and pressure of the inner ear, which helps to relieve symptoms associated with Meniere's disease such as vertigo, tinnitus, hearing loss and aural fullness. It is commonly used in the UK for the prophylaxis of this condition due to its effectiveness and relatively low side effect profile.<br /><br /><b>Promethazine</b> and <b>Prochlorperazine</b> are both antiemetics that can be used to manage acute episodes of vertigo associated with Meniere's disease. However, they do not prevent attacks from occurring. Instead, these medications work by blocking dopamine receptors in the brain's vomiting centre and chemoreceptor trigger zone, respectively. This helps to reduce nausea and vomiting during an attack but does not address the underlying pathology causing the symptoms.<br /><br /><b>Chlorphenamine</b> is an antihistamine primarily used for symptomatic relief of allergic conditions including rhinitis and urticaria. While it may have some minor effects on reducing fluid build-up in the inner ear due to its antihistamine properties, it is not typically used in the management or prevention of Meniere's disease.<br /><br />Finally, <b>Cinnarizine</b> is an antihistamine and calcium channel blocker that can also be used in managing vertigo symptoms. However, like Promethazine and Prochlorperazine, it does not prevent attacks from occurring but rather provides symptomatic relief during an episode of vertigo.",
        "answer_order": "3",
        "answer": "3",
        "title": "Meniere's disease",
        "body": "Meniere's disease is a disorder of the inner ear of unknown cause. It is characterised by excessive pressure and progressive dilation of the endolymphatic system. It is more common in middle-aged adults but may be seen at any age. Meniere's disease has a similar prevalence in both men and women.<br /><br />Features<br /><ul><li><span class=\"concept\" data-cid=\"1658\">recurrent episodes of vertigo, tinnitus and hearing loss</span> (sensorineural). Vertigo is usually the prominent symptom</li><li>a sensation of aural fullness or pressure is now recognised as being common</li><li>other features include nystagmus and a positive Romberg test</li><li>episodes last minutes to hours</li><li>typically symptoms are unilateral but bilateral symptoms may develop after a number of years</li></ul><br />Natural history<br /><ul><li>symptoms resolve in the majority of patients after 5-10 years</li><li>the majority of patients will be left with a degree of hearing loss</li><li>psychological distress is common</li></ul><br />Management<br /><ul><li>ENT assessment is required to confirm the diagnosis</li><li>patients should inform the DVLA. The current advice is to cease driving until satisfactory control of symptoms is achieved</li><li>acute attacks: buccal or intramuscular prochlorperazine. Admission is sometimes required</li><li>prevention: betahistine and vestibular rehabilitation exercises may be of benefit</li></ul>",
        "notes_hash": "0ad9ab0cd78bb488332e203a4b9481a4",
        "knowledge_graph_node_id_link": 1057,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "8316",
        "up_votes": "56",
        "down_votes": "13",
        "column_array": [
            0,
            "510",
            "2512",
            "4962",
            "125",
            "207",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/4YVfa1JFhu0\" data-description=\"Understanding M\u00c3\u00a9ni\u00c3\u00a8re\u00e2\u20ac\u2122s Disease\" data-upvotes=\"15\" data-downvotes=\"2\" data-media=\"1430\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/4YVfa1JFhu0/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/4YVfa1JFhu0\" data-description=\"Understanding M\u00c3\u00a9ni\u00c3\u00a8re\u00e2\u20ac\u2122s Disease\" data-upvotes=\"15\" data-downvotes=\"2\" data-media=\"1430\">Understanding M\u00c3\u00a9ni\u00c3\u00a8re\u00e2\u20ac\u2122s Disease</a></td></tr><tr><td><span ><small>Zero To Finals - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2525\" data-mediaid=\"2525\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2525\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">15</span><button type=\"button\" style=\"\" id=\"media_dislike_2525\" data-mediaid=\"2525\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2525\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr></table>",
        "comment_count": 4,
        "concepts_for_notes": [],
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_1685",
        "new_question_id": "7804",
        "question_type": "0",
        "category": "1",
        "concept_id_link": "0",
        "notes_id_link": "1_302",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "24 hour ECG monitor",
            "Echocardiogram",
            "Tilt table test",
            "CT head",
            "Carotid doppler",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 62-year-old man comes for review. In the past month he has had two episodes of 'passing out'. The first occurred whilst going upstairs. The second occurred last week whilst he was getting out of a swimming pool. There were no warning signs prior to these episodes. He was told by people who witnessed the episode last week that he was only 'out' for around 15 seconds. He reports feeling 'groggy' for only a few seconds after the episode. On examination pulse is 90 / minute, blood pressure 110/86 mmHg, his lungs are clear and there is a systolic murmur which radiates to the carotid area. Which one of the following investigations should be arranged first?",
            "",
            ""
        ],
        "answers": [
            "2",
            "",
            ""
        ],
        "notes": [
            "The systolic murmur may be a pointer to aortic stenosis (AS). Syncope is a late sign and typically occurs on exertion in patients with AS. It is therefore important to exclude this condition as a priority.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 62-year-old man comes for review. In the past month he has had two episodes of 'passing out'. The first occurred whilst going upstairs. The second occurred last week whilst he was getting out of a swimming pool. There were no warning signs prior to these episodes. He was told by people who witnessed the episode last week that he was only 'out' for around 15 seconds. He reports feeling 'groggy' for only a few seconds after the episode. On examination pulse is 90 / minute, blood pressure 110/86 mmHg, his lungs are clear and there is a systolic murmur which radiates to the carotid area. Which one of the following investigations should be arranged first?",
        "correct_answer": "2",
        "question_notes": "The systolic murmur may be a pointer to aortic stenosis (AS). Syncope is a late sign and typically occurs on exertion in patients with AS. It is therefore important to exclude this condition as a priority.",
        "answer_order": "2",
        "answer": "2",
        "title": "Aortic stenosis",
        "body": "<span class=\"concept\" data-cid=\"8264\">Clinical features</span> of symptomatic disease<br /><ul><li>chest pain</li><li>dyspnoea</li><li><span class=\"concept\" data-cid=\"11565\">syncope / presyncope (e.g. exertional dizziness)</span></li><li>murmur<ul><li>an <b>ejection systolic murmur</b> (ESM) is classically seen in aortic stenosis</li><li>classically radiates to the carotids</li><li>this is decreased following the <span class=\"concept\" data-cid=\"5832\">Valsalva manoeuvre</span></li></ul></li></ul><br />Features of severe aortic stenosis<br /><ul><li><span class=\"concept\" data-cid=\"8265\">narrow pulse pressure</span></li><li><span class=\"concept\" data-cid=\"8266\">slow rising pulse</span></li><li>delayed ESM</li><li><span class=\"concept\" data-cid=\"8267\">soft/absent S2</span></li><li><span class=\"concept\" data-cid=\"623\">S4</span></li><li>thrill</li><li>duration of murmur</li><li>left ventricular hypertrophy or failure</li></ul><br />Causes of aortic stenosis<br /><ul><li>degenerative calcification (most common cause in older patients > 65 years)</li><li>bicuspid aortic valve (most common cause in younger patients < 65 years)</li><li>William's syndrome (supravalvular aortic stenosis)</li><li>post-rheumatic disease</li><li>subvalvular: HOCM</li></ul><br />Management<br /><ul><li>if asymptomatic then observe the patient is a general rule</li><li>if <span class=\"concept\" data-cid=\"622\">symptomatic then valve replacement</span></li><li>if asymptomatic but <span class=\"concept\" data-cid=\"622\">valvular gradient > 40 mmHg</span> and with features such as left ventricular systolic dysfunction then consider surgery</li><li>options for <span class=\"concept\" data-cid=\"11728\">aortic valve replacement (AVR)</span> include:<ul><li>surgical AVR is the treatment of choice for young, low/medium operative risk patients. Cardiovascular disease may coexist. For this reason, an <span class=\"concept\" data-cid=\"4644\">angiogram</span> is often done prior to surgery so that the procedures can be combined</li><li>transcatheter AVR (TAVR) is used for patients with a high operative risk</li></ul></li><li>balloon valvuloplasty<ul><li>may be used in children with no aortic valve calcification</li><li>in adults limited to patients with critical aortic stenosis who are not fit for valve replacement</li></ul></li></ul>",
        "notes_hash": "e76a709d13a218a23b512513ec7d5f1d",
        "knowledge_graph_node_id_link": 1002,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "6527",
        "up_votes": "52",
        "down_votes": "74",
        "column_array": [
            0,
            "1291",
            "4532",
            "127",
            "109",
            "468",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>European Society of Cardiology</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_70\" data-linkid=\"70\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_70\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">14</span><button type=\"button\" style=\"\" id=\"link_dislike_70\" data-linkid=\"70\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_70\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">14</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Valvular-Heart-Disease-Guidelines\">2021 Valvular heart disease guidelines</a></td></tr></table><br><br><table style='width:100%'><tr><td>American Heart Association</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_71\" data-linkid=\"71\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_71\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">23</span><button type=\"button\" style=\"\" id=\"link_dislike_71\" data-linkid=\"71\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_71\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">13</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.ahajournals.org/doi/10.1161/CIR.0000000000000923\">Guidelines on the management of valvular heart disease</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/ifSJGLC55SU\" data-description=\"Aortic valve disease (bicuspid, tricuspid) - stenosis, regurgitation\" data-upvotes=\"9\" data-downvotes=\"2\" data-media=\"97\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/ifSJGLC55SU/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/ifSJGLC55SU\" data-description=\"Aortic valve disease (bicuspid, tricuspid) - stenosis, regurgitation\" data-upvotes=\"9\" data-downvotes=\"2\" data-media=\"97\">Aortic valve disease (bicuspid, tricuspid) - stenosis, regurgitation</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_161\" data-mediaid=\"161\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_161\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">9</span><button type=\"button\" style=\"\" id=\"media_dislike_161\" data-mediaid=\"161\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_161\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/mFQ2ea687Ps\" data-description=\"Aortic stenosis\" data-upvotes=\"17\" data-downvotes=\"4\" data-media=\"282\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/mFQ2ea687Ps/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/mFQ2ea687Ps\" data-description=\"Aortic stenosis\" data-upvotes=\"17\" data-downvotes=\"4\" data-media=\"282\">Aortic stenosis</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_483\" data-mediaid=\"483\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_483\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">17</span><button type=\"button\" style=\"\" id=\"media_dislike_483\" data-mediaid=\"483\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_483\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">4</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/Fb8E7dr6g0A\" data-description=\"Aortic stenosis murmur - REQUIRES HEADPHONES\" data-upvotes=\"9\" data-downvotes=\"3\" data-media=\"173\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/Fb8E7dr6g0A/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/Fb8E7dr6g0A\" data-description=\"Aortic stenosis murmur - REQUIRES HEADPHONES\" data-upvotes=\"9\" data-downvotes=\"3\" data-media=\"173\">Aortic stenosis murmur - REQUIRES HEADPHONES</a></td></tr><tr><td><span ><small>Thinklabs - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_301\" data-mediaid=\"301\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_301\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">9</span><button type=\"button\" style=\"\" id=\"media_dislike_301\" data-mediaid=\"301\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_301\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">3</span></td></tr></table>",
        "comment_count": 7,
        "concepts_for_notes": {
            "623": {
                "concept_text": "Aortic stenosis - S4 is a marker of severity",
                "concept_percentile": "11"
            },
            "8264": {
                "concept_text": "A 70-year-old man presents with chest pain and dyspnoea. On examination he has an ejection systolic murmur which radiates to his carotids - aortic stenosis",
                "concept_percentile": "36"
            },
            "8265": {
                "concept_text": "Aortic stenosis - narrow pulse pressure",
                "concept_percentile": "56"
            },
            "8266": {
                "concept_text": "Aortic stenosis - slow rising pulse",
                "concept_percentile": "22"
            },
            "8267": {
                "concept_text": "Aortic stenosis - a soft S2 is a feature of severe disease",
                "concept_percentile": "17"
            },
            "11565": {
                "concept_text": "Aortic stenosis may present with syncope / presyncope (e.g. exertional dizziness)",
                "concept_percentile": "54"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_423",
        "new_question_id": "3947",
        "question_type": "0",
        "category": "3",
        "concept_id_link": "0",
        "notes_id_link": "1_168",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Pregnancy",
            "Paget's disease",
            "Healing bone fractures",
            "Osteomalacia",
            "Hypoparathyroidism",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A rise in alkaline phosphatase can be caused by each one of the following except:",
            "",
            ""
        ],
        "answers": [
            "5",
            "",
            ""
        ],
        "notes": [
            "The correct answer is <b>Hypoparathyroidism</b>. Alkaline phosphatase (ALP) is an enzyme that is present in many tissues throughout the body, but primarily in the liver, bile ducts and bone. A rise in ALP levels can be caused by conditions that produce injury or inflammation to these tissues. Hypoparathyroidism, which involves decreased function of the parathyroid glands leading to low levels of parathyroid hormone (PTH), does not typically cause a rise in ALP. Instead, it leads to hypocalcaemia and hyperphosphatemia due to reduced bone turnover and renal phosphate excretion.<br /><br /><b>Pregnancy</b> can indeed cause a rise in ALP. This is because ALP is produced by the placenta, so levels naturally increase during pregnancy. It's also worth noting that there are several different types of ALP and the type found in the blood can help determine its source.<br /><br />In <b>Paget's disease</b>, there is excessive bone remodelling - breakdown and formation of bone tissue - which leads to increased activity of osteoblasts (cells responsible for bone formation). These cells produce ALP, so levels of this enzyme become elevated in this condition.<br /><br />Similarly, <b>Healing bone fractures</b> also lead to an increase in ALP levels. When a fracture occurs, osteoblasts are activated as part of the healing process and they release more ALP into circulation.<br /><br />Finally, <b>Osteomalacia</b>, a condition characterised by softening of the bones due to defective bone mineralisation (commonly due to Vitamin D deficiency), also causes raised ALP levels. In response to low calcium and phosphate levels within bones, osteoblasts increase the production of ALP.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A rise in alkaline phosphatase can be caused by each one of the following except:",
        "correct_answer": "5",
        "question_notes": "The correct answer is <b>Hypoparathyroidism</b>. Alkaline phosphatase (ALP) is an enzyme that is present in many tissues throughout the body, but primarily in the liver, bile ducts and bone. A rise in ALP levels can be caused by conditions that produce injury or inflammation to these tissues. Hypoparathyroidism, which involves decreased function of the parathyroid glands leading to low levels of parathyroid hormone (PTH), does not typically cause a rise in ALP. Instead, it leads to hypocalcaemia and hyperphosphatemia due to reduced bone turnover and renal phosphate excretion.<br /><br /><b>Pregnancy</b> can indeed cause a rise in ALP. This is because ALP is produced by the placenta, so levels naturally increase during pregnancy. It's also worth noting that there are several different types of ALP and the type found in the blood can help determine its source.<br /><br />In <b>Paget's disease</b>, there is excessive bone remodelling - breakdown and formation of bone tissue - which leads to increased activity of osteoblasts (cells responsible for bone formation). These cells produce ALP, so levels of this enzyme become elevated in this condition.<br /><br />Similarly, <b>Healing bone fractures</b> also lead to an increase in ALP levels. When a fracture occurs, osteoblasts are activated as part of the healing process and they release more ALP into circulation.<br /><br />Finally, <b>Osteomalacia</b>, a condition characterised by softening of the bones due to defective bone mineralisation (commonly due to Vitamin D deficiency), also causes raised ALP levels. In response to low calcium and phosphate levels within bones, osteoblasts increase the production of ALP.",
        "answer_order": "5",
        "answer": "5",
        "title": "Alkaline phosphatase",
        "body": "Causes of raised alkaline phosphatase (ALP)<br /><ul><li>liver: cholestasis, hepatitis, fatty liver, neoplasia</li><li>Paget's</li><li>osteomalacia</li><li><span class=\"concept\" data-cid=\"8561\">bone metastases</span></li><li>hyperparathyroidism</li><li>renal failure</li><li>physiological: <span class=\"concept\" data-cid=\"11201\">pregnancy</span>, growing children, healing fractures</li></ul><br />The table below splits the causes according to the calcium level<br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th><b>Raised ALP and raised calcium</b></th><th><b>Raised ALP and low calcium</b></th></tr></thead><tbody><tr><td><span class=\"concept\" data-cid=\"8561\">Bone metastases</span><br />Hyperparathyroidism<br /></td><td>Osteomalacia<br />Renal failure</td></tr></tbody></table></div>",
        "notes_hash": "c6d2f5a37f78cff12b1828745b41f212",
        "knowledge_graph_node_id_link": 0,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "5714",
        "up_votes": "23",
        "down_votes": "14",
        "column_array": [
            0,
            "534",
            "276",
            "624",
            "1192",
            "3088",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "",
        "comment_count": 0,
        "concepts_for_notes": {
            "8561": {
                "concept_text": "Raised ALP in the presence of normal LFT's should raise suspicion of malignancy. Particularly bone cancer/ metastases",
                "concept_percentile": "74"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "4564_B_38",
        "new_question_id": "14687",
        "question_type": "0",
        "category": "2",
        "concept_id_link": "3294",
        "notes_id_link": "1_1789",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Chloramphenicol eye drops",
            "Oral antibiotics",
            "Urgent ophthalmology referral",
            "Routine ophthalmology referral",
            "Reassurance and advice to continue conservative treatment unless symptoms persist beyond 1 year of age",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "The mother of a 6-month-old boy brings him to your clinic worried about recurrent sticky left eye. She describes constant watering of the left eye which at times becomes sticky but is not yellow or green. He has previously been treated twice with chloramphenicol drops which did not improve symptoms. An eye swab last month was negative. He is otherwise well in himself and has no problems with visual development. <br /><br />How would you manage this patient?",
            "",
            ""
        ],
        "answers": [
            "5",
            "0",
            "0"
        ],
        "notes": [
            "Congenital tear duct obstruction can lead to recurrent watery/sticky eyes in neonates. Patients will often have recurrent appointments for suspected conjunctivitis but will show only minimal improvement with chloramphenicol drops and have negative swabs. The majority of cases resolve by 1 year of age and so parents should be reassured. For persistent cases after 1-year routine ophthalmology referral is appropriate.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "The mother of a 6-month-old boy brings him to your clinic worried about recurrent sticky left eye. She describes constant watering of the left eye which at times becomes sticky but is not yellow or green. He has previously been treated twice with chloramphenicol drops which did not improve symptoms. An eye swab last month was negative. He is otherwise well in himself and has no problems with visual development. <br /><br />How would you manage this patient?",
        "correct_answer": "5",
        "question_notes": "Congenital tear duct obstruction can lead to recurrent watery/sticky eyes in neonates. Patients will often have recurrent appointments for suspected conjunctivitis but will show only minimal improvement with chloramphenicol drops and have negative swabs. The majority of cases resolve by 1 year of age and so parents should be reassured. For persistent cases after 1-year routine ophthalmology referral is appropriate.",
        "answer_order": "5",
        "answer": "5",
        "title": "Nasolacrimal duct obstruction",
        "body": "Nasolacrimal duct obstruction is the most common cause of a persistent watery eye in an infant. It is caused by an imperforate membrane, usually at the lower end of the lacrimal duct. Around 1 in 10 infants have symptoms at around one month of age<br /><br />Management<br /><ul><li>teach parents to massage the lacrimal duct</li><li>symptoms resolve in 95% by the age of one year. Unresolved cases should be referred to an ophthalmologist for consideration of probing, which is done under a light general anaesthetic</li></ul>",
        "notes_hash": "addaa526264b785d1c9e1a5eccd6ee60",
        "knowledge_graph_node_id_link": 0,
        "concept": "Congenital tear (lacrimal) duct obstruction is a cause of recurrent watery or sticky eye in neonates and usually, self-resolves by 1 year of age",
        "concept_percentile": "71",
        "concept_colour": "rgb(147,255,0)",
        "number_attempts": "5100",
        "up_votes": "49",
        "down_votes": "72",
        "column_array": [
            0,
            "53",
            "99",
            "2388",
            "593",
            "1967",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Patient.info</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1430\" data-linkid=\"1430\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1430\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">3</span><button type=\"button\" style=\"\" id=\"link_dislike_1430\" data-linkid=\"1430\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1430\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://patient.info/doctor/congenital-nasolacrimal-duct-obstruction\">Congenital nasolacrimal duct obstruction</a></td></tr></table>",
        "media": "",
        "comment_count": 6,
        "concepts_for_notes": [],
        "optimisation_reason": ""
    },
    {
        "question_id": "999_B_2138",
        "new_question_id": "61219",
        "question_type": "0",
        "category": "1",
        "concept_id_link": "9166",
        "notes_id_link": "1_1994",
        "theme": "Post-MI complication with new murmur and pulmonary oedema",
        "instruction": "",
        "options": [
            "",
            "Acute mitral regurgitation",
            "Ventricular septal defect",
            "Left ventricular free wall rupture",
            "Left ventricular aneurysm formation",
            "Post-infarction pericarditis",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 68-year-old man, 4 days post-inferior STEMI, develops sudden severe dyspnoea and hypotension. On examination, he has widespread bibasal crackles and a new pansystolic murmur at the apex, radiating to the axilla.<br /><br />Select the single most likely diagnosis from the options below.",
            "",
            ""
        ],
        "answers": [
            "1",
            "",
            ""
        ],
        "notes": [
            "<b>Acute mitral regurgitation</b> is the most likely diagnosis. This is a life-threatening mechanical complication of myocardial infarction, typically occurring 2-7 days post-event. It is more common following an infero-posterior MI, as the posterior papillary muscle often has a single blood supply (from the posterior descending artery), making it vulnerable to ischaemia and rupture. The clinical presentation is one of sudden haemodynamic collapse with hypotension and flash pulmonary oedema (indicated by severe dyspnoea and widespread crackles). This is because the non-compliant left atrium is suddenly exposed to high left ventricular systolic pressure, causing a rapid rise in pulmonary venous pressure. The new pansystolic murmur, heard best at the apex and radiating to the axilla, is characteristic of mitral regurgitation. While the murmur in acute MR can sometimes be early or mid-systolic and soft due to rapid pressure equalisation, a pansystolic murmur is also a recognised finding. The combination of an inferior MI, timing, and the specific signs of flash pulmonary oedema with an apical murmur makes this the most fitting diagnosis.<br /><br /><b>Ventricular septal defect</b> (VSD) is a key differential. It also presents with acute heart failure and a new pansystolic murmur, typically 3-5 days post-MI. However, the murmur of a VSD is classically loudest at the lower left sternal edge and is often accompanied by a palpable thrill. While it causes a left-to-right shunt leading to pulmonary congestion, the presentation with explosive, flash pulmonary oedema is more pathognomonic of acute mitral regurgitation. Furthermore, VSD is more commonly associated with large anterior MIs that affect the interventricular septum, whereas this patient had an inferior MI.<br /><br /><b>Left ventricular free wall rupture</b> is another catastrophic mechanical complication that typically occurs within the first two weeks post-MI. However, it leads to haemopericardium and cardiac tamponade. The clinical picture would be one of sudden hypotension, raised JVP, and muffled heart sounds (Beck's triad), often progressing rapidly to pulseless electrical activity (PEA) arrest. A new murmur and signs of pulmonary oedema are not typical features of free wall rupture, making it less likely in this scenario.<br /><br /><b>Left ventricular aneurysm formation</b> is a later complication, developing weeks to months after a large MI. It does not present with acute haemodynamic collapse. Instead, it typically leads to chronic heart failure, ventricular arrhythmias, or systemic embolisation from a mural thrombus. The presentation is subacute or chronic, which is inconsistent with the sudden deterioration described in this patient.<br /><br /><b>Post-infarction pericarditis</b> can occur within the first few days following a transmural MI. The classic presentation is pleuritic chest pain that is relieved by sitting forward. The characteristic examination finding is a pericardial friction rub, not a pansystolic murmur. While a large pericardial effusion could cause hypotension due to tamponade, it would not explain the new murmur or the florid pulmonary oedema. Therefore, this diagnosis does not fit the clinical picture.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 68-year-old man, 4 days post-inferior STEMI, develops sudden severe dyspnoea and hypotension. On examination, he has widespread bibasal crackles and a new pansystolic murmur at the apex, radiating to the axilla.<br /><br />Select the single most likely diagnosis from the options below.",
        "correct_answer": "1",
        "question_notes": "<b>Acute mitral regurgitation</b> is the most likely diagnosis. This is a life-threatening mechanical complication of myocardial infarction, typically occurring 2-7 days post-event. It is more common following an infero-posterior MI, as the posterior papillary muscle often has a single blood supply (from the posterior descending artery), making it vulnerable to ischaemia and rupture. The clinical presentation is one of sudden haemodynamic collapse with hypotension and flash pulmonary oedema (indicated by severe dyspnoea and widespread crackles). This is because the non-compliant left atrium is suddenly exposed to high left ventricular systolic pressure, causing a rapid rise in pulmonary venous pressure. The new pansystolic murmur, heard best at the apex and radiating to the axilla, is characteristic of mitral regurgitation. While the murmur in acute MR can sometimes be early or mid-systolic and soft due to rapid pressure equalisation, a pansystolic murmur is also a recognised finding. The combination of an inferior MI, timing, and the specific signs of flash pulmonary oedema with an apical murmur makes this the most fitting diagnosis.<br /><br /><b>Ventricular septal defect</b> (VSD) is a key differential. It also presents with acute heart failure and a new pansystolic murmur, typically 3-5 days post-MI. However, the murmur of a VSD is classically loudest at the lower left sternal edge and is often accompanied by a palpable thrill. While it causes a left-to-right shunt leading to pulmonary congestion, the presentation with explosive, flash pulmonary oedema is more pathognomonic of acute mitral regurgitation. Furthermore, VSD is more commonly associated with large anterior MIs that affect the interventricular septum, whereas this patient had an inferior MI.<br /><br /><b>Left ventricular free wall rupture</b> is another catastrophic mechanical complication that typically occurs within the first two weeks post-MI. However, it leads to haemopericardium and cardiac tamponade. The clinical picture would be one of sudden hypotension, raised JVP, and muffled heart sounds (Beck's triad), often progressing rapidly to pulseless electrical activity (PEA) arrest. A new murmur and signs of pulmonary oedema are not typical features of free wall rupture, making it less likely in this scenario.<br /><br /><b>Left ventricular aneurysm formation</b> is a later complication, developing weeks to months after a large MI. It does not present with acute haemodynamic collapse. Instead, it typically leads to chronic heart failure, ventricular arrhythmias, or systemic embolisation from a mural thrombus. The presentation is subacute or chronic, which is inconsistent with the sudden deterioration described in this patient.<br /><br /><b>Post-infarction pericarditis</b> can occur within the first few days following a transmural MI. The classic presentation is pleuritic chest pain that is relieved by sitting forward. The characteristic examination finding is a pericardial friction rub, not a pansystolic murmur. While a large pericardial effusion could cause hypotension due to tamponade, it would not explain the new murmur or the florid pulmonary oedema. Therefore, this diagnosis does not fit the clinical picture.",
        "answer_order": "1",
        "answer": "1",
        "title": "Myocardial infarction: complications",
        "body": "Patients are at risk of a number of immediate, early and late complications following a myocardial infarction (MI).<br /><br /><h5 class='notes-heading'>Cardiac arrest</h5><br />This most commonly occurs due to patients developing ventricular fibrillation and is the most common cause of death following a MI. Patients are managed as per the ALS protocol with defibrillation.<br /><br /><h5 class='notes-heading'>Cardiogenic shock</h5><br />If a large part of the ventricular myocardium is damaged in the infarction the ejection fraction of the heart may decrease to the point that the patient develops cardiogenic shock. This is difficult to treat. Other causes of cardiogenic shock include the 'mechanical' complications such as left ventricular free wall rupture as listed below. Patients may require inotropic support and/or an intra-aortic balloon pump.<br /><br /><h5 class='notes-heading'>Chronic heart failure</h5><br />As described above, if the patient survives the acute phase their ventricular myocardium may be dysfunctional resulting in chronic heart failure. Loop diuretics such as furosemide will decrease fluid overload. Both ACE-inhibitors and beta-blockers have been shown to improve the long-term prognosis of patients with chronic heart failure.<br /><br /><h5 class='notes-heading'>Tachyarrhythmias</h5><br /><span class=\"concept\" data-cid=\"6891\">Ventricular fibrillation</span>, as mentioned above, is the most common cause of death following a MI. Other common arrhythmias including ventricular tachycardia.<br /><br /><h5 class='notes-heading'>Bradyarrhythmias</h5><br />Atrioventricular block is more common following <span class=\"concept\" data-cid=\"7726\">inferior myocardial infarctions</span>.<br /><br /><h5 class='notes-heading'>Pericarditis</h5><br /><span class=\"concept\" data-cid=\"4052\">Pericarditis in the first 48 hours following a transmural MI is common</span> (c. 10% of patients). The pain is typical for pericarditis (worse on lying flat etc), a pericardial rub may be heard and a pericardial effusion may be demonstrated with an echocardiogram.<br /><br /><span class=\"concept\" data-cid=\"6892\">Dressler's syndrome</span> tends to occur around <span class=\"concept\" data-cid=\"1868\">2-6 weeks</span> following a MI. The underlying pathophysiology is thought to be an autoimmune reaction against antigenic proteins formed as the myocardium recovers. It is characterised by a combination of <span class=\"concept\" data-cid=\"6897\">fever</span>, <span class=\"concept\" data-cid=\"6898\">pleuritic pain</span>, pericardial effusion and a raised ESR. It is treated with NSAIDs.<br /><br /><span class=\"concept\" data-cid=\"6893\"><h5 class='notes-heading'>Left ventricular aneurysm</h5></span><br /><br />The ischaemic damage sustained may weaken the myocardium resulting in aneurysm formation. This is typically associated with <span class=\"concept\" data-cid=\"6900\">persistent ST elevation</span> and left ventricular failure. Thrombus may form within the aneurysm increasing the risk of stroke. Patients are therefore anticoagulated.<br /><br /><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg095b.png\" data-fancybox=\"gallery\" data-caption=\"Left ventricular aneurysm. ST-elevation with QS-waves and upright T-waves. The T/QRS ratio is much more suggestive of an LV aneurysm rather than an acute myocardial infarction. - e Image used on license from Dr Smith, University of Minnesota\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg095.png\" alt=\"\" /></a></div></div></div><br /><span class=\"concept\" data-cid=\"6894\"><h5 class='notes-heading'>Left ventricular free wall rupture</h5></span><br /><br />This is seen in around 3% of MIs and occurs around 1-2 weeks afterwards. Patients present with acute heart failure secondary to cardiac tamponade (<span class=\"concept\" data-cid=\"6899\">raised JVP, pulsus paradoxus</span>, diminished heart sounds). Urgent pericardiocentesis and thoracotomy are required.<br /><br /><span class=\"concept\" data-cid=\"6895\"><h5 class='notes-heading'>Ventricular septal defect</h5></span><br /><br />Rupture of the interventricular septum usually occurs in the first week and is seen in around 1-2% of patients. Features: acute heart failure associated with a pan-systolic murmur. An echocardiogram is diagnostic and will exclude acute mitral regurgitation which presents in a similar fashion. Urgent surgical correction is needed.<br /><br /><h5 class='notes-heading'>Acute mitral regurgitation</h5><br />More common with infero-posterior infarction and may be due to <span class=\"concept\" data-cid=\"5382\">ischaemia or rupture of the papillary muscle</span>. Acute hypotension and <span class=\"concept\" data-cid=\"9166\">pulmonary oedema</span> may occur. An early-to-mid systolic murmur is typically heard. Patients are treated with vasodilator therapy but often require emergency surgical repair.",
        "notes_hash": "5683d376eef16e9a6a9598d1113aa6e7",
        "knowledge_graph_node_id_link": 0,
        "concept": "Flash pulmonary oedema can occur after acute mitral valve regurgitation due to myocardial infarction",
        "concept_percentile": "96",
        "concept_colour": "rgb(20,255,0)",
        "number_attempts": "221",
        "up_votes": "0",
        "down_votes": "0",
        "column_array": [
            0,
            "131",
            "20",
            "56",
            "11",
            "3",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>European Society of Cardiology</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1300\" data-linkid=\"1300\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1300\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">53</span><button type=\"button\" style=\"\" id=\"link_dislike_1300\" data-linkid=\"1300\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1300\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">30</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.escardio.org/static_file/Escardio/Guidelines/2017%20STEMI%20ehx393_web%20addenda%20-%20FOR%20WEB.pdf\">2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation</a></td></tr></table>",
        "media": "",
        "comment_count": 2,
        "concepts_for_notes": {
            "5382": {
                "concept_text": "Rupture of the papillary muscle due to a myocardial infarction --> acute mitral regurgitation --> widespread systolic murmur, hypotension, pulmonary oedema",
                "concept_percentile": "60"
            },
            "6891": {
                "concept_text": "A man develops a cardiac arrest shortly after being admitted with a myocardial infarction. The ECG monitor shows rapid, irregular waveforms - ventricular fibrillation",
                "concept_percentile": "36"
            },
            "6892": {
                "concept_text": "A man presents with central, pleuritic chest pain and fever 4 weeks following a myocardial infarction. The ESR is elevated - Dressler's syndrome",
                "concept_percentile": "64"
            },
            "6893": {
                "concept_text": "A patient is noted to have persistent ST elevation 4 weeks after sustaining a myocardial infarction. Examination reveals bibasal crackles and the presence of a third and fourth heart sound - left ventricular aneurysm",
                "concept_percentile": "27"
            },
            "6894": {
                "concept_text": "A patient develops acute heart failure 10 days following a myocardial infarction. On examination he has a raised JVP, pulsus paradoxus and diminished heart sounds - left ventricular free wall rupture",
                "concept_percentile": "42"
            },
            "6895": {
                "concept_text": "A patient develops acute heart failure 5 days after a myocardial infarction. A new pan-systolic murmur is noted on examination - ventricular septal defect",
                "concept_percentile": "32"
            },
            "6897": {
                "concept_text": "Dressler's syndrome - persistent fever following a myocardial infarction",
                "concept_percentile": "41"
            },
            "6898": {
                "concept_text": "Pleuritic chest pain, MI 4 weeks ago - Dressler syndrome",
                "concept_percentile": "60"
            },
            "6899": {
                "concept_text": "Sudden heart failure, raised JVP, pulsus parodoxus, recent MI - left ventricular free wall rupture",
                "concept_percentile": "71"
            },
            "6900": {
                "concept_text": "Persistent ST elevation following recent MI, no chest pain - left ventricular aneurysm",
                "concept_percentile": "70"
            },
            "7726": {
                "concept_text": "AV block can occur following an inferior MI",
                "concept_percentile": "69"
            },
            "9166": {
                "concept_text": "Flash pulmonary oedema can occur after acute mitral valve regurgitation due to myocardial infarction",
                "concept_percentile": "96"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_962",
        "new_question_id": "2258",
        "question_type": "0",
        "category": "7",
        "concept_id_link": "0",
        "notes_id_link": "1_1300",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Normal development",
            "Isolated delay in gross motor skills",
            "Global developmental delay",
            "Isolated delay in fine motor skills",
            "Isolated delay in speech",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A mother brings her 9-month-old child to surgery. She is concerned he is not developing normally and is 'falling behind' the children of her friends. Whilst observing the child you notice he sits without support but makes little effort to move around the room. He has a crude pincer grip, appears shy when you try to interact and says 'mama' but little else. What is the most accurate description of his development?",
            "",
            ""
        ],
        "answers": [
            "1",
            "",
            ""
        ],
        "notes": [
            "The most accurate description of the child's development in this scenario is <b>Normal development</b>. This is because, according to the UK NHS guidelines, a 9-month-old child should be able to sit without support and have a crude pincer grip. They may also begin to say simple words like 'mama' or 'dada'. Shyness around strangers is also typical at this age as part of stranger anxiety, which reflects normal social-emotional development.<br /><br />The option <b>Isolated delay in gross motor skills</b> is incorrect because the child's ability to sit without support demonstrates that his gross motor skills are developing normally. Gross motor skills refer to movements involving larger muscle groups and typically include milestones such as sitting, crawling, standing and walking. At 9 months, it's not unusual for a child not to move around much.<br /><br /><b>Global developmental delay</b> would imply delays in multiple areas of development, including cognitive skills, social and emotional skills, speech and language skills, fine and gross motor skills. However, based on the information provided in the question stem, there doesn't seem to be evidence of delays across all these domains.<br /><br />An <b>Isolated delay in fine motor skills</b> would mean that the child has difficulty with tasks requiring precision and control such as picking up small objects or using utensils. However, this child shows a crude pincer grip (ability to hold an object between thumb and index finger), which is expected at his age.<br /><br />Finally, an <b>Isolated delay in speech</b> refers to when a child does not meet typical language milestones for their age group. According to NHS guidelines again though, saying simple words like 'mama' at 9 months old falls within normal speech development parameters.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A mother brings her 9-month-old child to surgery. She is concerned he is not developing normally and is 'falling behind' the children of her friends. Whilst observing the child you notice he sits without support but makes little effort to move around the room. He has a crude pincer grip, appears shy when you try to interact and says 'mama' but little else. What is the most accurate description of his development?",
        "correct_answer": "1",
        "question_notes": "The most accurate description of the child's development in this scenario is <b>Normal development</b>. This is because, according to the UK NHS guidelines, a 9-month-old child should be able to sit without support and have a crude pincer grip. They may also begin to say simple words like 'mama' or 'dada'. Shyness around strangers is also typical at this age as part of stranger anxiety, which reflects normal social-emotional development.<br /><br />The option <b>Isolated delay in gross motor skills</b> is incorrect because the child's ability to sit without support demonstrates that his gross motor skills are developing normally. Gross motor skills refer to movements involving larger muscle groups and typically include milestones such as sitting, crawling, standing and walking. At 9 months, it's not unusual for a child not to move around much.<br /><br /><b>Global developmental delay</b> would imply delays in multiple areas of development, including cognitive skills, social and emotional skills, speech and language skills, fine and gross motor skills. However, based on the information provided in the question stem, there doesn't seem to be evidence of delays across all these domains.<br /><br />An <b>Isolated delay in fine motor skills</b> would mean that the child has difficulty with tasks requiring precision and control such as picking up small objects or using utensils. However, this child shows a crude pincer grip (ability to hold an object between thumb and index finger), which is expected at his age.<br /><br />Finally, an <b>Isolated delay in speech</b> refers to when a child does not meet typical language milestones for their age group. According to NHS guidelines again though, saying simple words like 'mama' at 9 months old falls within normal speech development parameters.",
        "answer_order": "1",
        "answer": "1",
        "title": "Development problems",
        "body": "<b>Abnormal development or developmental delay</b> refers to a significant lag in a child's physical, cognitive, behavioural, emotional, or social development, relative to established growth milestones. It is crucial for clinicians to identify and address these delays promptly to improve long-term outcomes.<br /><br /><br /><h5 class='notes-heading'>Background</h5><br />The process of normal child development is complex and multifaceted, encompassing the maturation of various systems such as motor skills (gross and fine), language (expressive and receptive), cognitive abilities, and adaptive behaviours. Any disruption in this intricate process can lead to abnormal development. The root cause may be genetic disorders, prenatal exposure to toxins/drugs/alcohol, premature birth, nutritional deficiencies or environmental factors.<br /><br /><br /><h5 class='notes-heading'>Example issues</h5><br />Referral points<br /><ul><li>doesn't smile at 10 weeks</li><li>cannot sit unsupported at 12 months</li><li>cannot walk at 18 months</li></ul><br />Fine motor skill problems<br /><ul><li>hand preference before 12 months is abnormal and may indicate cerebral palsy</li></ul><br />Gross motor problems<br /><ul><li>most common causes of problems: variant of normal, cerebral palsy and neuromuscular disorders (e.g. Duchenne muscular dystrophy)</li></ul><br />Speech and language problems<br /><ul><li>always check hearing</li><li>other causes include environmental deprivation and general development delay</li></ul><br /><h5 class='notes-heading'>Differential Diagnosis</h5><br />The differential diagnosis for developmental delay is broad; however, some common causes include:<br /><br /><ul><li><b>Autism Spectrum Disorder (ASD)</b>: Characterised by impairments in social interaction and communication alongside restricted interests and repetitive behaviours.</li><li><b>Cerebral Palsy:</b> A group of permanent movement disorders appearing in early childhood due to abnormal brain development or damage.</li><li><b>Fragile X Syndrome:</b> A genetic condition causing intellectual disability, behavioural challenges and various physical characteristics.</li><li><b>Down Syndrome:</b> A chromosomal disorder leading to intellectual disability and characteristic facial features.</li><li><b>Fetal Alcohol Spectrum Disorders (FASDs):</b> A range of effects that can occur in an individual exposed to alcohol before birth.</li></ul><br /><h5 class='notes-heading'>Initial Management</h5><br />The initial management of a child with suspected developmental delay involves the following steps:<br /><br /><ul><li><b>Clinical Examination:</b> A thorough physical and neurological examination to assess the child's developmental milestones.</li><li><b>Investigations:</b> These may include genetic testing, metabolic screening, neuroimaging studies (MRI or CT scan), and hearing/vision assessments.</li><li><b>Referral for Specialist Assessment:</b> If a specific cause is suspected, referral to a paediatric neurologist, geneticist or developmental paediatrician may be necessary.</li><li><b>Early Intervention Services:</b> Regardless of the underlying cause, all children with developmental delays can benefit from early intervention services such as occupational therapy, speech and language therapy, physiotherapy and educational support.</li></ul>",
        "notes_hash": "adcefb7d367ce09a84ddc40d84638d6a",
        "knowledge_graph_node_id_link": 11154,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "5847",
        "up_votes": "26",
        "down_votes": "56",
        "column_array": [
            0,
            "3599",
            "1051",
            "666",
            "404",
            "127",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "",
        "comment_count": 9,
        "concepts_for_notes": [],
        "optimisation_reason": ""
    }
]